Contraception
Volume 77, Issue 6 , Page 466, June 2008

Erratum to “Subject and clinician experience with the levonorgestrel-releasing intrauterine system”

[Contraception 77(2008) 22–29]

  • Jeffrey T. Jensen

      Affiliations

    • Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA
    • Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR 97239, USA
    • Corresponding Author InformationCorresponding author. UHN-70 Oregon Health and Science University, Portland, OR 97239, USA. Tel.: +1 503 494 4469; fax: +1 503 494 5083.
    • ,
  • Anita L. Nelson

      Affiliations

    • Department of Obstetrics and Gynecology, Harbor-UCLA Medical Center, Torrance, CA 90502, USA
    • ,
  • Antonio C. Costales

      Affiliations

    • Medical Affairs, Women’s HealthCare, Bayer HealthCare Pharmaceuticals, Inc., Wayne, NJ 07470, USA

published online 14 April 2008.

Article Outline

 

In the above article, the sentence on page 22 in the second paragraph of the “Introduction” that read “The LNG IUS is approved for use as a contraceptive in the United States for up to 7 years but is approved for use for 5 years in the United States [4]” should have read “The LNG IUS is approved for use as a contraceptive in the United States for up to 5 years [4].”

The authors regret any inconvenience or confusion this error may have caused.

PII: S0010-7824(08)00130-3

doi:10.1016/j.contraception.2008.03.005

Refers to article:

  • Subject and clinician experience with the levonorgestrel-releasing intrauterine system , 23 November 2007

    Jeffrey T. Jensen, Anita L. Nelson, Antonio C. Costales
    Contraception January 2008 (Vol. 77, Issue 1, Pages 22-29)

Contraception
Volume 77, Issue 6 , Page 466, June 2008

Article Tools